Publication | Open Access

Discovery of new quinazoline derivatives as irreversible dual EGFR/HER2 inhibitors and their anticancer activities – Part 1

Molecular PharmacologyMedicinal ChemistryPart 1Pharmaceutical ChemistryAnticancer ActivitiesDrug TargetingMedicineNatural SciencesRational Drug DesignAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyRadiation OncologyNew Quinazoline DerivativesDrug Discovery